Study: NCT01379209

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGI-2001
Description: A single administration of RGI-2001 on Day 0 post AHSCT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcineurin Inhibitors
Description: GVHD prophylaxis according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: According to institutional guidelines.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Conditioning Regimen
Description: Myeloablative preparative treatment according to institutional guidelines. Subjects could have received any number/combinations of treatments.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Conditioning Regimen
Description: Myeloablative preparative treatment according to institutional guidelines. Subjects could have received any number/combinations of treatments.